Medicine and Dentistry
Thrombosis
100%
Antiplatelet Drug
100%
Bruton Tyrosine Kinase
100%
Bruton Tyrosine Kinase Inhibitor
100%
B Cell
66%
Cancer
33%
Cell Differentiation
33%
Drug Megadose
33%
Platelet
33%
Bleeding
33%
Bleeding Diathesis
33%
Cell Proliferation
33%
Low Drug Dose
33%
Ibrutinib
33%
Acalabrutinib
33%
X Linked Agammaglobulinemia
33%
Keyphrases
Antiplatelet Drugs
100%
Atherothrombosis
100%
Bruton's Tyrosine Kinase
100%
Bruton Tyrosine Kinase Inhibitor
100%
Platelets
33%
Mechanistic Insight
33%
Bleeding
33%
Bleeding Tendency
33%
B-cell Malignancies
33%
B Cell Differentiation
33%
High-dose Therapy
33%
Ibrutinib
33%
Acalabrutinib
33%
X-linked Agammaglobulinemia
33%
β-cell Proliferation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombosis
100%
Antithrombocytic Agent
100%
Bruton Tyrosine Kinase
100%
Bruton Tyrosine Kinase Inhibitor
100%
Bleeding
33%
Bleeding Tendency
33%
Ibrutinib
33%
Acalabrutinib
33%
X Linked Agammaglobulinemia
33%
INIS
drugs
100%
tyrosine
100%
kinases
100%
doses
33%
patients
16%
therapy
16%
reviews
16%
malignancies
16%
cell proliferation
16%
cell differentiation
16%